Pediatric Crohn's disease from onset to adulthood: granulomas are associated with an early need for immunomodulation

Area of Science:

• Pediatric Gastroenterology
• Inflammatory Bowel Disease Research
• Histopathology

Background:

• Childhood onset Crohn's disease (CD) is often more aggressive than adult-onset disease.
• Epithelioid cell granulomas in intestinal biopsies are a non-obligate diagnostic criterion for CD.
• The prognostic significance of granulomas in pediatric CD requires further investigation.

Purpose of the Study:

• To investigate the association between epithelioid cell granulomas in pediatric CD patients and disease severity.
• To evaluate granulomas as potential markers for disease aggressiveness in children followed into adulthood.

Main Methods:

• A cohort of 45 individuals with childhood onset CD was followed from diagnosis to final height.
• Diagnostic intestinal biopsies were reviewed for the presence of granulomas in a blinded manner.
• Data on disease location, management, and growth parameters were analyzed.

Main Results:

• Granulomas were identified in 49% of patients at diagnosis and 62% during the disease course.
• A significantly shorter time to initiating immune modulating treatment was observed in the granuloma-positive group (p=0.01).
• The presence of granulomas did not correlate with height standard deviation scores at diagnosis or final adult height.

Conclusions:

• Epithelioid cell granulomas in pediatric Crohn's disease are associated with a more rapid initiation of immune modulating therapy, suggesting increased disease severity.
• Despite this association, granulomas did not appear to negatively affect the final adult height of patients.
• Granulomas may serve as a useful histopathological marker for identifying children with potentially more aggressive CD requiring earlier intervention.